Carmat Aeson® Artificial Heart Shows Promise for Pulmonary Hypertension Patients
A single-center study at the University Medical Center of Astana, Kazakhstan, demonstrated the effectiveness of the Aeson® total artificial...
Dupixent® FDA Priority Review for Bullous Pemphigoid Treatment
Regeneron and Sanofi announced that the FDA accepted for Priority Review their supplemental Biologics License Application for Dupixent (dupilumab)...
ICON Discusses How AI is Changing Clinical Trial Recruitment and Diversity
In this discussion with Kathleen Mandziuk, Vice President of eClinical Development & Delivery at ICON, we explore the dynamic...
Where is RBQM Heading in The Future With AI?
Richard Young, Chief Strategy Officer at CluePoints, shares insights on AI and risk-based quality management (RBQM) in clinical trials....
EU Approves First Self-Amplifying mRNA COVID-19 Vaccine
CSL and Arcturus Therapeutics announced that the European Commission has approved KOSTAIVE (ARCT-154), a self-amplifying mRNA COVID-19 vaccine, for...
ORYZON Announces Journal Publication of Final Phase IIa REimagine Results with Vafidemstat
Oryzon Genomics announced the publication of final Phase IIa REIMAGINE study results, demonstrating the safety and efficacy of vafidemstat...
Benitec Biopharma’s BB-301 Study at MDA Conference
Benitec Biopharma announced interim clinical study updates for the first three subjects in its Phase 1b/2a trial of BB-301,...
Next-Gen Nectin-4 Targeting ADC Shows Promise in Phase 1 Study
Corbus Pharmaceuticals announced positive data from its US and UK Phase 1 dose escalation study of CRB-701, a next-generation...
Medicus Pharma Announces SKNJC-003 Phase 2 Nodular BCC Study Update
Medicus Pharma Ltd. (NASDAQ: MDCX) announced that its Phase 2 clinical trial (SKNJCT-003) for D-MNA, a treatment for basal...
StemSpine® Procedure Significantly Reduces Opioid Use in Chronic Lower Back Pain Patients
Creative Medical Technology Holdings (CELZ) announced positive mid-term results from its StemSpine pilot study using AlloStem cells to treat...